328 related articles for article (PubMed ID: 33777052)
21. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome.
Maria NI; van Helden-Meeuwsen CG; Brkic Z; Paulissen SM; Steenwijk EC; Dalm VA; van Daele PL; Martin van Hagen P; Kroese FG; van Roon JA; Harkin A; Dik WA; Drexhage HA; Lubberts E; Versnel MA
Arthritis Rheumatol; 2016 Jul; 68(7):1688-99. PubMed ID: 26866723
[TBL] [Abstract][Full Text] [Related]
22. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
23. Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives.
Godin-Ethier J; Hanafi LA; Piccirillo CA; Lapointe R
Clin Cancer Res; 2011 Nov; 17(22):6985-91. PubMed ID: 22068654
[TBL] [Abstract][Full Text] [Related]
24. Tryptophan-kynurenine profile in pediatric autoimmune hepatitis.
Lytton SD; Osiecki M; MałgorzataWoźniak ; Cukrowska B; Wierzbicka A; Goliszek M; Socha P; Janczyk W; Dayanakli D; Abendroth D; Kramp S; Fechner K; Scheper T; Mahler M; Bentow C; Bogdanos D; Fuchs D; Woynarowski M
Immunol Res; 2019 Feb; 67(1):39-47. PubMed ID: 30666511
[TBL] [Abstract][Full Text] [Related]
25. IDO/kynurenine pathway in cancer: possible therapeutic approaches.
Abd El-Fattah EE
J Transl Med; 2022 Aug; 20(1):347. PubMed ID: 35918736
[TBL] [Abstract][Full Text] [Related]
26. Role of tryptophan metabolism in cancers and therapeutic implications.
Liu XH; Zhai XY
Biochimie; 2021 Mar; 182():131-139. PubMed ID: 33460767
[TBL] [Abstract][Full Text] [Related]
27. Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases.
Heidari F; Ramezani A; Erfani N; Razmkhah M
Int Rev Immunol; 2022; 41(3):346-363. PubMed ID: 33118843
[TBL] [Abstract][Full Text] [Related]
28. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
29. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
[TBL] [Abstract][Full Text] [Related]
30. Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct.
Söderlund J; Erhardt S; Kast RE
J Neuroinflammation; 2010 Aug; 7():44. PubMed ID: 20691089
[TBL] [Abstract][Full Text] [Related]
31. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment.
Azimnasab-Sorkhabi P; Soltani-Asl M; Yoshinaga TT; Zaidan Dagli ML; Massoco CO; Kfoury Junior JR
Mol Biol Rep; 2023 Jul; 50(7):6133-6145. PubMed ID: 37217614
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of indoleamine 2,3-dioxygenase correlates with regulatory T cell phenotype in acute myeloid leukemia patients with normal karyotype.
Arandi N; Ramzi M; Safaei F; Monabati A
Blood Res; 2018 Dec; 53(4):294-298. PubMed ID: 30588466
[TBL] [Abstract][Full Text] [Related]
33. PCC0208009 enhances the anti-tumor effects of temozolomide through direct inhibition and transcriptional regulation of indoleamine 2,3-dioxygenase in glioma models.
Sun S; Du G; Xue J; Ma J; Ge M; Wang H; Tian J
Int J Immunopathol Pharmacol; 2018; 32():2058738418787991. PubMed ID: 29993291
[TBL] [Abstract][Full Text] [Related]
34. Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.
Sun J; Yu J; Li H; Yang L; Wei F; Yu W; Liu J; Ren X
J Exp Clin Cancer Res; 2011 Sep; 30(1):82. PubMed ID: 21917155
[TBL] [Abstract][Full Text] [Related]
35. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
36. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
[TBL] [Abstract][Full Text] [Related]
37. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
[TBL] [Abstract][Full Text] [Related]
38. The role of indoleamine 2,3-dioxygenase in allergic disorders.
Esmaeili SA; Hajavi J
Mol Biol Rep; 2022 Apr; 49(4):3297-3306. PubMed ID: 35028850
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells.
Iachininoto MG; Nuzzolo ER; Bonanno G; Mariotti A; Procoli A; Locatelli F; De Cristofaro R; Rutella S
Molecules; 2013 Aug; 18(9):10132-45. PubMed ID: 23973990
[TBL] [Abstract][Full Text] [Related]
40. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.
Thomas SR; Stocker R
Redox Rep; 1999; 4(5):199-220. PubMed ID: 10731095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]